These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 9201793)

  • 1. Improvement of schizophrenic symptoms and changes in plasma HVA concentrations, plasma anti-D2 and anti-5-HT2 receptor activities with clozapine.
    Yamada K; Kanba S; Wang ZC; Suzuki E; Fang YY; Yan HG; Nibuya M; Yagi G; Asai M
    Psychiatry Clin Neurosci; 1996 Oct; 50(5):291-4. PubMed ID: 9201793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia.
    Kapur S; Zipursky RB; Remington G
    Am J Psychiatry; 1999 Feb; 156(2):286-93. PubMed ID: 9989565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypothesis testing: is clozapine's superior efficacy dependent on moderate D2 receptor occupancy?
    Carpenter WT; Zito JM; Vitrai J; Volavka J
    Biol Psychiatry; 1998 Jan; 43(2):79-83. PubMed ID: 9474440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine.
    Markianos M; Hatzimanolis J; Lykouras L; Christodoulou GN
    Schizophr Res; 2002 Jul; 56(1-2):11-7. PubMed ID: 12084414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of clozapine and risperidone on 5-HT2 and D2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study.
    Hall H; Halldin C; Nyberg S; Farde L; Sedvall G
    Eur Neuropsychopharmacol; 1995 Mar; 5(1):19-25. PubMed ID: 7542051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effect of haloperidol and clozapine on plasma homovanillic acid in elderly schizophrenic patients with or without tardive dyskinesia.
    Andia I; Zumarraga M; Zabalo MJ; Bulbena A; Davila R
    Biol Psychiatry; 1998 Jan; 43(1):20-3. PubMed ID: 9442340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography.
    Schotte A; Janssen PF; Megens AA; Leysen JE
    Brain Res; 1993 Dec; 631(2):191-202. PubMed ID: 7510574
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The dopamine-serotonin relationship in clozapine response.
    Szymanski S; Lieberman J; Pollack S; Munne R; Safferman A; Kane J; Kronig M; Cooper T
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S85-9. PubMed ID: 7530378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine2 receptor occupancy and the action of clozapine: does it make a difference to add a neuroleptic?
    Meltzer HY
    Biol Psychiatry; 1999 Jul; 46(1):144-9. PubMed ID: 10394487
    [No Abstract]   [Full Text] [Related]  

  • 10. Plasma homovanillic acid, plasma anti-D1 and -D2 dopamine-receptor activity, and negative symptoms in chronically mediated schizophrenia.
    Suzuki E; Kanba S; Nibuya M; Koshikawa H; Nakaki T; Yagi G
    Biol Psychiatry; 1992 Feb; 31(4):357-64. PubMed ID: 1348430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurochemical variables in schizophrenic patients during switching from neuroleptics to clozapine.
    Hatzimanolis J; Lykouras L; Markianos M; Oulis P
    Prog Neuropsychopharmacol Biol Psychiatry; 1998 Oct; 22(7):1077-85. PubMed ID: 9829289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of a selective D4 dopamine receptor antagonist (L-745,870) in acutely psychotic inpatients with schizophrenia. D4 Dopamine Antagonist Group.
    Kramer MS; Last B; Getson A; Reines SA
    Arch Gen Psychiatry; 1997 Jun; 54(6):567-72. PubMed ID: 9193198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of loxapine on peripheral dopamine-like and serotonin receptors in patients with schizophrenia.
    Singh AN; Barlas C; Saeedi H; Mishra RK
    J Psychiatry Neurosci; 2003 Jan; 28(1):39-47. PubMed ID: 12587849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.
    Kapur S; Zipursky RB; Remington G; Jones C; DaSilva J; Wilson AA; Houle S
    Am J Psychiatry; 1998 Jul; 155(7):921-8. PubMed ID: 9659858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
    Seeman P; Tallerico T
    Mol Psychiatry; 1998 Mar; 3(2):123-34. PubMed ID: 9577836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of short-term changes in symptom severity by baseline plasma homovanillic acid levels in schizophrenic patients receiving clozapine.
    Sumiyoshi T; Hasegawa M; Jayathilake K; Meltzer HY
    Psychiatry Res; 1997 Mar; 69(2-3):113-21. PubMed ID: 9109179
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clozapine, single photon emission tomography, and the D2 dopamine receptor blockade hypothesis of schizophrenia.
    Pilowsky LS; Costa DC; Ell PJ; Murray RM; Verhoeff NP; Kerwin RW
    Lancet; 1992 Jul; 340(8813):199-202. PubMed ID: 1353135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The striatal and extrastriatal D2/D3 receptor-binding profile of clozapine in patients with schizophrenia.
    Gründer G; Landvogt C; Vernaleken I; Buchholz HG; Ondracek J; Siessmeier T; Härtter S; Schreckenberger M; Stoeter P; Hiemke C; Rösch F; Wong DF; Bartenstein P
    Neuropsychopharmacology; 2006 May; 31(5):1027-35. PubMed ID: 16237387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in plasma homovanillic acid concentrations in schizophrenic patients following neuroleptic discontinuation.
    Davidson M; Kahn RS; Powchik P; Warne P; Losonczy MF; Kaminsky R; Apter S; Jaff S; Davis KL
    Arch Gen Psychiatry; 1991 Jan; 48(1):73-6. PubMed ID: 1670618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment with clozapine and its effect on plasma homovanillic acid and norepinephrine concentrations in schizophrenia.
    Davidson M; Kahn RS; Stern RG; Hirschowitz J; Apter S; Knott P; Davis KL
    Psychiatry Res; 1993 Feb; 46(2):151-63. PubMed ID: 8483974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.